LKB1; linking cell structure and tumor suppression
- PMID: 19029933
- DOI: 10.1038/onc.2008.342
LKB1; linking cell structure and tumor suppression
Abstract
Germ line mutations in the LKB1 tumor suppressor gene are associated with the Peutz-Jeghers polyposis and cancer syndrome. Somatic mutations in Lkb1 are observed in sporadic pulmonary, pancreatic and biliary cancers and melanomas. The LKB1 serine-threonine kinase functionally and biochemically links control of cellular structure and energy utilization through activation of the AMPK family of kinases. Lkb1 regulates cell polarity through downstream kinases including AMPKs, MARKs and BRSKs, and nutrient utilization and cellular metabolism through the AMPK-mTOR pathway. LKB1 has been shown to affect normal chromosomal segregation, TGF-beta signaling in the mesenchyme and WNT and p53 activity. Although each of the LKB1-dependent processes and downstream pathways have been individually delineated through work across a range of experimental systems, how they relate to Lkb1's role as a tumor suppressor remains to be fully explored and elucidated. The recent development of mouse cancer models harboring engineered mutations in Lkb1 have offered insights into how LKB1 may be functioning to restrain tumorigenesis and how its role as a master regulator of polarity and metabolism could contribute to its tumor suppressor function.
Similar articles
-
Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.Hum Mol Genet. 2005 May 15;14(10):1283-92. doi: 10.1093/hmg/ddi139. Epub 2005 Mar 30. Hum Mol Genet. 2005. PMID: 15800014
-
LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.Physiol Rev. 2009 Jul;89(3):777-98. doi: 10.1152/physrev.00026.2008. Physiol Rev. 2009. PMID: 19584313 Review.
-
Molecular mechanisms of tumor suppression by LKB1.FEBS Lett. 2011 Apr 6;585(7):944-51. doi: 10.1016/j.febslet.2010.12.034. Epub 2010 Dec 27. FEBS Lett. 2011. PMID: 21192934 Review.
-
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.Oncogene. 2004 Jun 24;23(29):5084-91. doi: 10.1038/sj.onc.1207665. Oncogene. 2004. PMID: 15077168
-
Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.Cancer Res. 1998 Apr 1;58(7):1384-6. Cancer Res. 1998. PMID: 9537235
Cited by
-
Liver kinase B1 (LKB1) regulates the epigenetic landscape of mouse pancreatic beta cells.FASEB J. 2024 Aug 31;38(16):e23885. doi: 10.1096/fj.202401078R. FASEB J. 2024. PMID: 39139039
-
Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.Curr Issues Mol Biol. 2024 Jun 26;46(7):6440-6471. doi: 10.3390/cimb46070385. Curr Issues Mol Biol. 2024. PMID: 39057027 Free PMC article. Review.
-
Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers.Res Sq [Preprint]. 2024 Jul 2:rs.3.rs-4587317. doi: 10.21203/rs.3.rs-4587317/v1. Res Sq. 2024. PMID: 39011112 Free PMC article. Preprint.
-
Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.Signal Transduct Target Ther. 2024 Jan 5;9(1):11. doi: 10.1038/s41392-023-01706-y. Signal Transduct Target Ther. 2024. PMID: 38177135 Free PMC article.
-
STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines.Cancer Gene Ther. 2024 Jan;31(1):1-8. doi: 10.1038/s41417-023-00687-y. Epub 2023 Nov 15. Cancer Gene Ther. 2024. PMID: 37968341 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
